Clinical trials
catalyst calendar across sponsors →Studies where KHC is the lead sponsor, as filed with ClinicalTrials.gov. Completion dates are the sponsor's own projected windows and are revised as a study runs. Active studies first, then completed and stopped — newest readout first within each.
1 interventional
Held by 22 tracked-famous managers (Berkshire Hathaway Inc, AQR CAPITAL MANAGEMENT LLC, SOUTHEASTERN ASSET MANAGEMENT INC/TN/, CITADEL ADVISORS LLC, GATES FOUNDATION TRUST, +17 more) · FINRA short interest 6.1 days to cover (settled 2026-07-31) · insider 90d: 0 buys / 1 sells · government filings 180d: 2 congress / 4 executive
| Study | Phase | Status | Interventions | Conditions | Enrollment | Primary completion | Updated |
|---|---|---|---|---|---|---|---|
| A Controlled-Feeding Study to Assess the Effect of Cashews on Fasting Lipoprotein LevelsNCT02769741Change in LDL-C concentration measured in bloodRandomized · Double-masked · Prevention | Not applicable | Completed | Other: Cashews followed by Control, Control followed by Cashews | Healthy Volunteers | 51 | Jun 2016actual | 2016-11-01 |
Primary completion is the date the sponsor filed with the registry — their own projection, revised whenever they revise it, unless the row is marked actual.
Source: ClinicalTrials.gov, retrieved 2026-08-19